(Q54437993)

29 May 2018

title

p53 and HER-2 alterations in renal cell carcinoma. (English)

1 reference

29 May 2018

author name string

Zhang XH

1

1 reference

29 May 2018

Takenaka I

2

1 reference

29 May 2018

Sato C

3

1 reference

29 May 2018

Sakamoto H

4

1 reference

29 May 2018

language of work or name

English

0 references

publication date

1 October 1997

1 reference

29 May 2018

published in

Urology

1 reference

29 May 2018

volume

50

1 reference

29 May 2018

issue

4

1 reference

29 May 2018

page(s)

636-642

1 reference

29 May 2018

Suppression of human colorectal carcinoma cell growth by wild-type p53

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

In primary human breast carcinomas mutations in exons 5 and 6 of the p53 gene are associated with a high S-phase index

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

Mutations in the p53 gene occur in diverse human tumour types

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

p53 mutations and overexpression in locally advanced breast cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

p53 mutations have no additional prognostic value over stage in bladder cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

Proliferating cell nuclear antigen but not p53 or human papillomavirus DNA correlates with advanced clinical stage in renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

Prognostic factors in renal-cell carcinoma: immunohistochemical detection of p53 protein versus clinico-pathological parameters

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

Evaluation of c-erbB-2 amplification in breast carcinoma by differential polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

Validation of a differential PCR and an ELISA procedure in studying HER-2/neu status in breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

Expression of proliferating cell nuclear antigen (PC10), p53 protein and c-erbB-2 in renal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

Expression of HER-2/neu in renal-cell carcinoma. Correlation with histologic subtypes and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

C-erbB-2 immunostaining: problems with interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

c-erbB-2 in astrocytomas: infrequent overexpression by immunohistochemistry and absence of gene amplification by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2897%2900258-6

7 January 2021

10.1016/S0090-4295(97)00258-6

Identifiers

DOI

1 reference

29 May 2018

PubMed ID

9338750

1 reference

29 May 2018